Himelstein-Braw, R, Peters, H and Faber, M. Morphological study of the ovaries of leukaemic children. Br J Cancer 1978; 38:82–87.CrossRefGoogle ScholarPubMed

Chapman, RM, Sutcliffe, SB and Malpas, JS.Cytotoxic-induced ovarian failure in women with Hodgkin’s disease. I. Hormone function. JAMA 1979; 242:1877–81.Google ScholarPubMed

Swerdlow, AJ, Cooke, R, Bates, A et al. Risk of premature menopause after treatment for Hodgkin’s lymphoma. J Natl Cancer Inst 2014;106.Google Scholar

Bramswig, JH, Riepenhausen, M and Schellong, G. Parenthood in adult female survivors treated for Hodgkin’s lymphoma during childhood and adolescence: a prospective, longitudinal study. Lancet Oncol 2015; 16:667–75.Google Scholar

Wallace, WH, Thomson, AB, Saran, F and Kelsey, TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005; 62:738–44.Google Scholar

Wallace, WH, Critchley, HO and Anderson, RA. Optimizing reproductive outcome in children and young people with cancer. J Clin Oncol 2012; 30:3–5.Google Scholar

Lawrenz, B, Fehm, T, von Wolff, M et al.Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma–evaluation by using antimullerian hormone and retrieved oocytes. Fertil Steril 2012; 98:141–44.Google Scholar

Friedler, S, Koc, O, Gidoni, Y, Raziel, A and Ron-El, R. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril 2012; 97:125–33.Google Scholar

Anderson, RA, Mitchell, RT, Kelsey, TW et al.Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol 2015; 3:556–67.Google Scholar

Petrek, JA, Naughton, MJ, Case, LD et al.Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006; 24:1045–51.Google Scholar

Chow, EJ, Stratton, KL, Leisenring, WM et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 2016; 17:567–76.Google Scholar

Letourneau, JM, Ebbel, EE, Katz, PP et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer 2012; 118:1933–39.Google Scholar

Brook, JD, Gosden, RG and Chandley, AC. Maternal ageing and aneuploid embryos–evidence from the mouse that biological and not chronological age is the important influence. Hum Genet 1984; 66:41–45.Google Scholar

Anderson, RA, Adamson, D, Yellowlees, A et al.Administration of a GnRH agonist during chemotherapy during chemotherapy for breast cancer reduces ovarian toxicity in women aged under 40 years. ESHRE Meeting, Helskinki 2016:P488.Google Scholar

Anderson, RA, Rosendahl, M, Kelsey, TW and Cameron, DA. Pretreatment anti-Mullerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. Eur J Cancer 2013; 49:3404–11.Google Scholar

Su, HC, Haunschild, C, Chung, K et al.Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients. Cancer 2014; 120:3691–98.Google Scholar

De Vos, M, Smitz, J and Woodruff, TK. Fertility preservation in women with cancer. Lancet 2014; 384:1302–10.Google Scholar

Cobo, A, Garcia-Velasco, JA, Coello, A et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril 2016; 105:755–64 e758.Google Scholar

Doyle, JO, Richter, KS, Lim, J et al.Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril 2016; 105:459–66 e452.Google Scholar

Donnez, J, Dolmans, MM, Pellicer, A et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 2013; 99:1503–13.Google Scholar

Van der Ven, H, Liebenthron, J, Beckmann, M et al. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod 2016; 31:2031–41.Google Scholar

Dolmans, MM, Luyckx, V, Donnez, J, Andersen, CY and Greve, T. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril 2013; 99:1514–22.Google Scholar

Waxman, JH, Ahmed, R, Smith, D et al. Failure to preserve fertility in patients with Hodgkin’s disease. Cancer Chemother Pharmacol 1987; 19:159–62.CrossRefGoogle ScholarPubMed

Del Mastro, L, Boni, L, Michelotti, A et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 2011; 306 :269–76.Google ScholarPubMed

Moore, HC, Unger, JM, Phillips, KA et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med 2015; 372:923–32.CrossRefGoogle ScholarPubMed

Lambertini, M, Ceppi, M, Poggio, F et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol 2015; 26:2408–19.Google Scholar

Leonard, R, Adamson, D, Bertelli, G et al. GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial. Ann Oncol 2017; 28:1811–16.CrossRefGoogle ScholarPubMed

Demeestere, I, Brice, P, Peccatori, FA et al. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol 2016.Google Scholar